Caution Regarding Assessment of Toxic Effects and Survival in Treatment De-escalation With Radiotherapy vs Transoral Surgery for Human Papillomavirus–Associated Oropharyngeal Cancer-Reference-Cited by-同舟云学术

Caution Regarding Assessment of Toxic Effects and Survival in Treatment De-escalation With Radiotherapy vs Transoral Surgery for Human Papillomavirus–Associated Oropharyngeal Cancer

Published:2022-10-01 Issue:10 Volume:8 Page:1511
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

De Virgilio Armando¹²,Costantino Andrea¹²,Spriano Giuseppe¹²

Affiliation:

1. Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy

2. Otorhinolaryngology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2795423/jamaoncology_de_virgilio_2022_le_220023_1666196334.68764.pdf

Reference3 articles.

1. Assessment of toxic effects and survival in treatment deescalation with radiotherapy vs transoral surgery for HPV-associated oropharyngeal squamous cell carcinoma: the ORATOR2 phase 2 randomized clinical trial.;Palma;JAMA Oncol,2022

2. Bleeding complications after transoral robotic surgery: a meta-analysis and systematic review.;Stokes;Laryngoscope,2021

3. Spondylodiscitis after transoral robotic surgery: retrospective 7-case series from the GETTEC group.;Carpentier;Eur Ann Otorhinolaryngol Head Neck Dis,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective Treatment Deintensification by Reducing Radiation Dose and Omitting Concurrent Chemotherapy Based on Response to Induction Chemotherapy in Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma: A Single-Arm, Phase 2 Trial (IChoice-01);International Journal of Radiation Oncology*Biology*Physics;2024-01

2. Trans oral robotic surgery for oropharyngeal cancer: A multi institutional experience;European Journal of Surgical Oncology;2023-09

3. Strahlentherapie oder Operation bei HPV-positiven Oropharynxkarzinomen? Die ORATOR2-Studie – ein Vergleich von Birnen und Äpfeln;Laryngo-Rhino-Otologie;2023-03